AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy for 2027? The Motley Fool 16:08 Fri, 20 Nov
Judge dismisses Tampa General lawsuit against Eli Lilly over 340B reporting demands WUSF Public Media 17:51 Thu, 19 Nov
Isomorphic Labs adds Merck as an oncology partner after $5 billion raise Drug Discovery & Development 17:15 Thu, 19 Nov
Eli Lilly: Everyone Losing Weight, But Lilly Keeps Gaining (Initiating With A Buy) Seeking Alpha 09:38 Thu, 19 Nov
Gold, Silver and Crude Slide Hard as Volatility Jumps on the Week PR Newswire (Press Release) 05:33 Thu, 19 Nov
Lilly's EloraTZP Brought Up to 77% of Adults With Diabetes to Normal Blood Sugar in Phase 2 Trial Medical Daily 21:05 Wed, 18 Nov
Retatrutide Brought Up to Half of Nondiabetic Sleep Apnea Patients to Mild or No Disease in NEJM Trials Medical Daily 19:34 Wed, 18 Nov
Rhythm Pharma: Is AstraZeneca/Eli Lilly's Bidding War For Real? Don't Rule It Out Seeking Alpha 19:24 Wed, 18 Nov
Eli Lilly vs. Novo Nordisk: Which GLP-1 Stock Is a Better Buy for 2027? The Motley Fool 21:39 Tue, 17 Nov
Eli Lilly (LLY) Showcased Its Obesity Pipeline, Is It Still 3% Undervalued? Simply Wall St 20:18 Tue, 17 Nov
Eli Lilly inks cancer pact worth up to $5.9bn with Stipple Bio Pharmaceutical Technology 17:08 Tue, 17 Nov
Teva v. Lilly: Judge Dyk’s Dissent Highlights Tension Between Method Claims and Genus Enablement JD Supra 15:58 Tue, 17 Nov
Retatrutide Cut Sleep Apnea Breathing Events Up to 60.6% in Lilly Trial, but the Weekly Shot Remains Unapproved Medical Daily 05:54 Tue, 17 Nov
Stocks Carry Weekly Gains Into a Wall of Chart Resistance as Volatility Cools PR Newswire (Press Release) 00:31 Tue, 17 Nov
Zepbound Lowered Teens' BMI 18.5% to 21.4% in 72-Week Trial, but Most Had Stomach Side Effects Medical Daily 23:38 Mon, 16 Nov
Where Will Eli Lilly Be in 10 Years? 1 Clue: Its Next Potential Blockbuster Just Beat Ozempic Head-to-Head The Motley Fool 19:10 Mon, 16 Nov
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know Zacks 15:01 Mon, 16 Nov
Lilly Acquires Calytrix Bio To Advance Treatments For Essential Thrombocythemia And Myelofibrosis RTT News 13:08 Mon, 16 Nov
Calytrix Bio enters an agreement to be acquired by Lilly to advance outcomes for patients living with essential thrombocythemia and myelofibrosis PR Newswire (Press Release) 11:47 Mon, 16 Nov
Seawolf Therapeutics Debuts With $100 Million to Advance DNA-Based Therapeutics Business Wire (Press Release) 10:05 Mon, 16 Nov
Prediction: $10,000 Equally Split Between Eli Lilly and Novo Nordisk Will Be Worth This Much by the End of 2027 The Motley Fool 00:00 Mon, 16 Nov
Learn Why The Bull Case For Eli Lilly (LLY) Could Change Following Obesity Drug Trial Results Simply Wall St 08:38 Sun, 15 Nov
Eli Lilly (LLY) Faces New Vision Loss Lawsuits As Pipeline Milestones Keep Coming Simply Wall St 07:32 Sat, 14 Nov
Weekly Gains Hold Up Despite a Friday Slide as Chips Lead and Yields Climb PR Newswire (Press Release) 20:50 Fri, 13 Nov
Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say STAT 09:35 Fri, 13 Nov
Eli Lilly beats Novo to oral China GLP-1RA market on NMPA approval Pharmaceutical Technology 09:29 Fri, 13 Nov
Eli Lilly becomes first drugmaker to have a GLP-1 weight-loss pill approved in China AsiaOne 09:17 Fri, 13 Nov